Showing results (161-170 of 225) with videos related to
Sort By:
Pageof 23
International Journal of Molecular Sciences|April 3, 2021
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In VitroHirofumi Ohashi, Feng Wang, Frank Stappenbeck, et al.The Journal of Antibiotics|May 30, 2024
Isolation, structural determination, and antiviral activities of a novel alanine-conjugated polyketide from Talaromyces spNozomi Mosu, Mitsuki Yasukochi, Shogo Nakajima, et al.Biochemical and Biophysical Research Communications|July 20, 2023
Selective inhibition of hepatitis B virus internalization by oxysterol derivativesMizuki Oshima, Frank Stappenbeck, Hirofumi Ohashi, et al.Journal of Virology|October 25, 2019
Surfeit 4 Contributes to the Replication of Hepatitis C Virus Using Double-Membrane VesiclesLingbao Kong, Haruyo Aoyagi, Zibing Yang, et al.Scientific Reports|June 28, 2016
Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virusRyohei Saga, Akira Fujimoto, Noriyuki Watanabe, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 23, 2019
Anti-viral effects of interferon-λ3 on hepatitis B virus infection in cell cultureNorie Yamada, Asako Murayama, Masaaki Shiina, et al.Hepatology (Baltimore, Md.)|December 31, 2013
Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)Koichi Watashi, Ann Sluder, Takuji Daito, et al.Journal of Virology|May 24, 2019
Small Interfering RNA Screening for the Small GTPase Rab Proteins Identifies Rab5B as a Major Regulator of Hepatitis B Virus ProductionJun Inoue, Masashi Ninomiya, Teruyuki Umetsu, et al.Elife|January 16, 2026
Stratification of viral shedding patterns in saliva of COVID-19 patientsHyeongki Park, Yoshimura Raiki, Shoya Iwanami, et al.Biochemical and Biophysical Research Communications|May 7, 2018
A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interactionWakana Saso, Senko Tsukuda, Hirofumi Ohashi, et al.Pageof 23